Purpose: To evaluate and compare response and toxicities in patients treated with chemoradiation alone and chemoradiation with high dose rate intraluminal brachytherapy in carcinoma of the esophagus.
Material and methods: A total of 60 patients were included in the study and were divided randomly into 1 arms -CT RT arm and ILBT arm with 30 patients each. CT RT received definitive chemoradiation 54 Gy in 27 fractions with concurrent weekly cisplatin and ILBT received definitive chemoradiation 50 Gy in 25 fractions with concurrent weekly cisplatin followed by two sessions of intraluminal brachytherapy of 4 Gy each. Evaluation of early response was done 1 and 6 months after completion of chemoradiation on a clinical basis and by upper GI endoscopy. Dysphagia scores were recorded before, on completion of treatment and in the 1 st and 6 th month of follow-up. Acute gastro-intestinal toxicities (fistula, stricture, ulcer, esophagitis) were evaluated.
Results: The patient characteristics were comparable in both the arms. Dysphagia to solids was more frequent in the chemoradiation alone arm compared to the ILBT arm at the end of 1 month and 6 months. 80% had a complete clinical response in the CT-RT arm compared to 86.7.3% in the ILBT arm. Grade 3 stricture was more frequent in arm 2. Grade 2 ulceration was seen only in arm 2. None of the patients developed fistula or pneumonitis. There was improvement in dysphagia in both the arms with 50% in arm 1 and 67% in arm 2 tolerating a normal solid diet at the end of 6 months.
Conclusions: Chemoradiation with ILBT for carcinoma of the esophagus provides excellent local control of the disease with acceptable toxicities when compared with chemoradiation alone.
MRI-based image-guided brachytherapy for cervical cancer in an Indian tertiary centre -a single institute's experience.
Dr. Jaswanthi AR, Dr. Richa Tiwari, Dr Geeta SN Department of Radiation Oncology, Vydehi Institute of Medical Sciences, Bangalore Purpose: To analyse the outcomes of MR based IGBT in our hospital.
Material and methods: 151 biopsy proven cervical cancer patients with stage IB2-IVA were recruited at Vydehi Hospital, Bangalore. MRI scans were acquired as a routine investigation for all the patients before the start of whole pelvic EBRT. All the patients had undergone EBRT to a dose of 45-50 Gy in conventional fractionation or VMAT with concurrent weekly chemotherapy. Radiologically if there was presence of pelvic LN ≥ 1 cm in the greatest dimension, then the node was boosted to 55 Gy by EBRT. Brachytherapy was undertaken under spinal anaesthesia after the 3rd week of EBRT if the patients were suitable. IC OR IC-ISBT was done. After assessing the extent of residual disease under anaesthesia, appropriate MR-compatible intracavitary applicators (tandem-ovoids/tandem-ring/tandem with ring and interstitial needles/tandem with cylinder and interstitial needles) were used for the procedure. The 1st fraction of BT in all patients was planned on MRI and the subsequent fractions on CT simulated images.
Results: Purpose: To dosimetrically compare multicatheter interstitial brachytherapy (MIBT) and intensity modulated radiotherapy (VMAT) for accelerated partial breast irradiation (APBI) with the focus on dose to organs at risk.
Material and methods: Twenty-one patients with early stage breast cancer treated in the Department of Radiotherapy and Oncology, Shirdi Sai baba Cancer Hospital, KMC Manipal during 2016-2019 with MIBT were selected for the study. For each patient an additional VMAT treatment plan was created using the same CT data and contours as used in MIBT plans. OARs included ipsilateral and contralateral breast, lung of both sides, skin, and heart. The CTV was created from the outlined lumpectomy cavity. The PTV in VMAT plans was generated from CTV with the addition of an isotropic 5 mm margin. Purpose: Stated as the most mobile part of the LGI tract and within clinical and dosimetric preview of ICBT in cancer cervix, sigmoid colon dosimetry and toxicity is less studied with respect to its rectal counterpart. With endoscopic data suggesting a proportional increase of ICBT related LGI toxicity to RSJ, our study aimed at estimation of sigmoid movements with respect to interfractional imaging and its dosimetric impact.
Material and methods: 7 patients (FIGO IB3-IIIB) were treated with EBRT (50 Gy/25 #) using 3D-CRT and ICBT (7 Gy/3 #) ± nodal boost. During ICBT, sigmoid contouring was done from the RSJ to the superior aperture of the lesser pelvis. A standard bowel and bladder protocol was followed. Sigmoid movement was measured in 2 axes (anterosuperior, posteroinferior) based on a line from the top of the symphysis pubis to the S1-2 junction in sagittal section (Rt and left lateral) based on the AP line from the symphysis pubis to the coccyx (axial section). Interfractional differences in volumes (cc) in each quadrant were correlated with D 2cc of that quadrant and the sigmoid. A 2 cm radius sphere was contoured from the central tandem with cranial extent of 1 cm and caudally up to cervical os. The impact of rectal volume, arching/crossing of sigmoid over the uterus was estimated.
Results: Most interfractional movement was observed in the anterosuperior quadrant (range, 4-38 cc). Ratio of total volume/D 2cc was lower in the posteroinferior quadrant (mean 4.08, range, 1.43-11.5). Dosimetric data of 21# analysed suggest that minimal rectal volume (12 cc) is needed below which sigmoid D 2cc increases. Posteroinferior volume (p = 0.08) and D2cc (p = 0.08) correlated with Sphere D2cc. Sigmoid colon arching over uterus was more associated with higher D 2cc (p = 0.06) than crossing of the sigmoid (p = 0.1).
Conclusions: The anterosuperior part has more interfractional motion but does not effect OAR dose. Increase of volume in the posteroinferior part leads to overall D2cc increase. Minimal rectal filling is needed below which posteroinferior volume increases lead to a higher sigmoid dose. Arching of the sigmoid over the uterus needed optimisation in terms of dwell positions.
Xray vs. Ct-based planning for intracavitary brachytherapy in carcinoma cervix -a dosimetric analysis Material and methods: Patients with carcinoma of the uterine cervix treated between May 2017 and December 2018 with radical chemoradiation and high dose rate (HDR) ICBT were included. All the patients were treated with a standard dose of external beam radiotherapy (46-50 Gy) with weekly 40 mg/m 2 inj. cisplatin, followed by HDR ICBT to a dose of 7.5 Gy in 3 sessions. Each application underwent both X-ray and CT simulation and the dosimetric data for 74 conventional and CT-based ICBT plans were analyzed. Point A and ICRU 38 rectal and bladder points were defined on the conventional plan and CT plan. The doses to bladder and rectum were compared in both the plans. The gross tumor volume (GTV), clinical target volume (CTV) and organs at risk (OAR)s were contoured on the CT plan according to GEC-ESTRO guidelines. With the same source configuration, the dose was prescribed to point A and CTV and respective volume coverage, D 1cc,2cc bladder and rectum volumes were compared.
Results: The mean of ICRU bladder point and rectal point in the conventional plan (X-ray) were 44.4% (3.33 Gy) with SD of ±19.84% (1.48 Gy) and 48.10% (3.6 Gy) ±13.71% (1.02 Gy). The mean of ICRU bladder and rectal point in the CT plan was 62.95% (4.72 Gy) ±22.71% (1.70 Gy) and 59.66% (4.47 Gy) ±17.16% (1.28 Gy). In the current study when the dose was prescribed to point A in CT, the bladder D 1cc was 78.83% (5.9 Gy) with SD of ±17.83% (1.33 Gy), bladder D 2cc was 68.58% (5.14 Gy) ±14.71% (1.10 Gy) and rectum D 1cc was 67.14% (5.03 Gy) ±20.15% (1.51 Gy), rectum D 2cc was 59.57% (4.46 Gy) ±17.9% (1.34 Gy). When the dose is prescribed to CTV the bladder D 1cc was 60.85% (4.56 Gy) with SD of ±19.82% (1.48 Gy), bladder D 2cc was 51.49% (3.86 Gy) ±15.70% (1.17 Gy) and rectum D 1cc was 41.57% (3.11 Gy) ±22.78% (1.7 Gy), rectum D 2cc was 36.53% (2.73 Gy) ±19.5% (1.46 Gy). The CTV coverage in the point A based plan was 91.67% ±7.09 and in the volume based plan was 96.58% ±3.44.
Conclusions: Comparison of orthogonal X-ray-based and CT-based HDR ICBT planning is feasible. The ICRU bladder and rectal point doses in 2D planning were lower compared to the ICRU bladder and rectal point doses in 3D planning. But D 1cc , D 2cc of bladder and rectal doses were lower in 3D planning compared to 2D planning due to normalization in 2D planning and optimization in 3D planning and also it was observed that the tumor coverage was better in 3D volume based planning compared to 2D point A based BT planning.
Influence of bladder volume and central tandem length on optimum dose to OAR in intracavitary brachytherapy of carcinoma cervix Results: Bladder: High-dose parameters of bladder are increased by increasing the bladder volume. Tandems longer than 4 cm increase the dose to the bladder up to about 4% (of the planning aim dose) more, compared to the shorter tandems; Rectum: Rectum dose reaches its minimum and maximum levels for < 70 cc and 110-170 cm 3 bladders, respectively. Choosing a longer tandem leads to about 5% higher dose to the rectum. Rectum volume does not have any drastic influence on the dose to rectum for patients whose tandems are ≤ 4 cm. Sigmoid: When the bladder volume is 70-75 cm 3 , the sigmoid dose will be minimum. Tandem lengths have a direct relationship with sigmoid dose.
Conclusions:
In conclusion, choosing a bladder with a volume of about 70 cm 3 or less and tandem length of < 4 cm is recommended when taking into account the high dose volume parameters for bladder, rectum, and sigmoid. An invasive procedure was performed under spinal and epidural anesthesia. EUA -external genitalia, vaginal length, tumor dimension, parametrial and paravaginal tissue involvement, and relationship of the tumor to the uterus and other pelvic organs as well as a thorough per-rectal examination is done. Foley's catheterization is done with the balloon filled with 7 ml of contrast. Bladder filling with 200 cc of normal saline and clamp the Foley catheter. The uterine sounding is done to assess the uterine length. The uterine tandem is placed into the uterine cavity. The vaginal length is determined and the vaginal obturator is inserted over the tandem until its tip abuts the cervical os. The base plate is fixed to the obturator with screws and to the perineum by stitches at 4 corners. A guide needle is inserted 3-4 cm beyond the clinically palpable disease, starting with the needles near the rectum, with one finger inside the rectum to avoid rectal perforation. The number and position of the needles are according to the extent of the disease. All the needle insertions are done under transabdominal USG guidance and the position is checked. The cover plate is placed over the template to prevent the needles' displacement.
Results: 20 patients had a complete response. 10 patients had a partial response and 10 patients had disease progression.
Conclusions: In conclusion, HDR-ISBT gives better results in locally advanced carcinoma cervix not suitable for intra cavitary brachytherapy. Purpose: This study aims to compare dosimetry and skin toxicity of patients treated with local tumour bed dose escalation (boost) with photon beams (external beam radiation therapy -EBRT) vs high-dose-rate interstitial brachytherapy (HDR-BT) after breast-conserving treatment in women with early-stage breast cancer.
Comparison of EBRt vs. interstitial brachytherapy boost in postBCS patients
Material and methods: Eligibility criteria: Age ≥ 18 years. Histologically confirmed carcinoma of breast, unilateral early breast cancer. Undergone breast conservation surgery followed by whole breast radiation therapy. Three dimensional conformal radiotherapy was planned as per conventional methods. The whole breast was treated to a total dose of 40 Gy in 15 consecutive daily fractions, 2.67 Gy per fraction. An additional boost dose was delivered either by ISBT or EBRT. Skin contouring was defined as a thick layer of 5 mm underneath the skin surface (Nandi M et al.) . All patients underwent clinical examination before irradiation, weekly during the treatment course and every three months for the first year. Acute skin toxicity was assessed during and at the completion of RT and after 1 month, 3 months, and 6 months. Late effects and cosmetic outcome were evaluated at each clinical visit.
Results: Skin toxicities during the end of radiation: grade 1 toxicity in 6 (1/5), grade 2 toxicity in 11 (6/5), grade 3 toxicity in 3 (6/0), grade 4 toxicity: nil. Observed in 1 patient in arm that received tumour bed boost by EBRT. Recurrence occurred within 1 cm from the surgical scar.
Conclusions: Tumour bed boost by interstitial brachytherapy has shown better tumour control with lower grades of skin toxicity.
Precision brachytherapy -ISBt in recurrent leiomyosarcoma
Dr Samantha Dsouza, Dr Hasib AG, Dr Donald Fernandes, Dr MS Athiyamaan, Dr Sharaschandra Shankar, Dr Sandesh Rao, Dr Mohsina, Dr Sheeba Department of Radiotherapy, Father Muller Medical College, Mangalore, India Purpose: Soft tissue sarcomas (STS) are a comparatively rare heterogeneous group of tumours with different distinct histopathological subtypes. It accounts for less than 1% of all adult solid neoplasms. Due to rarity of the occurrence and heterogeneous pathological varieties, STS have aggressive biological behaviour and high potential for local recurrence after surgery. Adjuvant radiation therapy, either preoperative or post-operative, improves local control rates after local resection or limb sparing surgery, eliminating the need for amputation in case of limb sarcoma.
Case details: A 45-year-old woman was diagnosed with fibroid uterus and underwent total abdominal hysterectomy after which she developed a swelling on the anterior abdominal wall. Wide local excision was done.
IHC showed features suggestive of myofibroblastic proliferation reactive for vimentin, CD99, SMA, and CD34; Ki-67 labelling index is 20%.
The patient developed recurrent swelling at the same site twice and was excised.
She received adjuvant radiation therapy 66 Gy with 33 fractions completed. She was on regular followup when she noticed a swelling in the right scapular region which was increasing in size. On examination, right shoulder -7 × 6 cm swelling present over the right scapular region. Skin over the swelling normal. Firm to hard in consistency. Fixed to underlying structure. MRI: mass lesion measuring 11 × 10.5 × 5.3 cm noted in the right infraspinatus muscle. Inferiorly fat planes with teres minor were maintained. Anterior portion of infraspinatus muscle was normal. She underwent wide local excision under GA with per op insertion of 8 ISBT catheters. HPE showed malignant soft tissue neoplasm -epithelioid malignant peripheral nerve sheath tumor. The external contours of the CTV were delineated on each CT slice in the 3D treatment planning system (Oncentra Brachytherapy Mode). HDR brachytherapy was performed using an 192 Ir remote after loading the system with the treatment device Nucleotron micro-Selectron using the prescription point at 1 cm from the catheters and a total prescription dose of 15 Gy in 5 sessions, 3 Gy per session, delivered through 8 ISBT catheters. Brachytherapy was started on POD 6. The patient is on regular follow-up and presently has no complaints and is planned for EBRT.
Results: For function preservation in the management of STS, a wide margin resection is the common surgical procedure. Local recurrence rates after conservative surgery alone have been unacceptably high (30-75%). Combination of surgery and ISBT with/without EBRT improves local and distant control with acceptable late toxicities.
Conclusions: In this case report we noted that local recurrence rate had significant control with ISBT. Long term follow-up is necessary to comment regarding late recurrences.
Shot in the eye: surface brachytherapy for eyelid tumours The general principles of radiation to skin cancer also apply to sebaceous carcinoma of the eyelid. We report the use of surface mould brachytherapy for adjuvant radiotherapy in eyelid tumors.
Case details: A 73-year-old man presented with a small, progressively increasing painless papule of 2 × 1.5 cm exuberant vegetative nodule with central crusting over the margin of the left upper eyelid. After detailed evaluation and review, left upper eyelid tumor excision and reconstruction was done. Histopathology revealed sebaceous carcinoma grade II with intraepithelial pagetoid spread and positive medial and lateral margin. Therefore, adjuvant RT was planned. Surface-mold technique was considered. With the help of a thermoplastic mold (to hold the catheter in place) and a wax spacer (as a separator), a single catheter was placed each time along the surgical scar and fixed to it with adhesive plaster. A corneal shield was used to further increase the distance between the catheter and the cornea. The patient received 40 Gy/9# over 5 days, with ≥ 6 hour inter-fraction interval.
Results: He tolerated the treatment well, with grade I skin reaction following treatment completion. At oneyear follow-up, the patient has no recurrence, and has no long-term sequelae of brachytherapy.
Conclusions: Surface-mold brachytherapy could be considered in selected patients with eyelid tumors.
Best poster presentation session
Promising outcomes of perioperative interstitial brachytherapy in treatment and prevention of keloid recurrence Dr. Kirthi Koushik MD, Dr Anu George Department of Radiation Oncology, MS Ramaiah Medical College, Bangalore, India Purpose: The aim of this study is to analyse treatment outcomes of perioperative interstitial brachytherapy in keloids.
Material and methods: From 2014 to 2016, 20 patients who underwent keloid excision and were referred for adjuvant RT were analysed retrospectively. After excision of keloid, brachytherapy tubes were placed subcutaneously before closing the wound and radiation to a total dose of 15 Gy in 3 divided doses was delivered on day 1, 2, 3 of surgical excision.
Results: The median age was 29 years (range: 18-71); 50% of patients were male and 50% female. The most common site of keloid was ear lobe (40%) followed by sternum (20%) and forearm (15%). The most common presenting complaints were cosmesis, itching and pain. 30% of patients had received a previous treatment, either surgery or corticosteroid injection, and had recurrence in the same region. The median size of keloid before brachytherapy was 80 mm 3 . The median followup was 3.8 years. 5 patients had local recurrence (26%) and median time to recur was 8 months. 1 patient had recurrence outside the treated region. No treatment-related complications (infection) were seen in any patients. All patients reported symptomatic and cosmetic improvement at 1-year follow-up.
Conclusions: Peri-operative radiation therapy can reduce the risk of keloid recurrence. Our study shows good local control of 73%, hence suggesting that HDR brachytherapy with 3 fractions of 5 Gy each is a safe and effective dosage schedule for postoperative adjuvant radiotherapy in management of keloids.
Retrospective study of outcomes in carcinoma cervix involving up to lower third of vagina Purpose: According to FIGO staging of cervical cancer, involvement of the lower third of the vagina is considered as IIIA. There are limited studies of treatment outcomes in these patients. Narrowing of the vagina from invasion of tumor may cause improper intracavitary brachytherapy (ICBT) leading to an insufficient radiation dose delivered. Therefore, these patients have higher risk of persistent or local recurrence (LR). The usual tandem and ovoids application does not provide a sufficient dose to the lower third of the vagina. So either tandem and cylinder or interstitial brachytherapy is done in these patients. The study aims to observe the response to radiotherapy.
Material and methods: Patients with confirmed pathological results of squamous cell carcinoma cervix and who received complete radiation therapy.
Results: The total number of patients included in this study was 56, of whom 5 patients were lost to follow up, so 51 patients were included. Median followup of these patients is 36 months (12-72 months). 11.7% (6) patients developed grade 2 proctitis, 1.9% (1) developed grade 3 proctitis. 3.9% (2) patients developed grade 3 small bowel toxicities. No urinary bladder toxicities were noted. All the toxicities are observed in the patients treated with tandem and cylinder.
Conclusions: There is a smaller amount of data regarding stage IIIA carcinoma cervix. In our study we provided the results attained in our institute. The toxicity of radiotherapy is less when interstitial brachytherapy is done than tandem cylinder.
Retrospective study on pattern of failure following brachytherapy in carcinoma cervix: a single institutional experience Results: Out of 230 patients, 68 (29.5%) patients presented with failure and recurrence. Among those, 68.21% of patients did not complete radiation, 32% of patients did not receive radiation in an adjuvant setting. The most common sites of distant failure were paraaortic node (42%), lung (31%), bones (15%), liver (12%). Treatment time, EBRT and ICBT gap and mean EQD 2 point A were found to be associated with a better outcome in terms of DFS.
Conclusions: Both failure and recurrence depend upon age and stage at presentation, point A cumulative dose and treatment gap. The failure can be reduced if the patients are educated about the importance of completing both EBRT and brachytherapy without defaulting the treatment. An interesting result was that follow-up pattern had a significant impact on DFS period.
Primary vaginal carcinoma in a long standing uterine prolapse treated with radical surgery, EBRt and surface mould brachytherapy: a case report Results: Post brachytherapy he had a good response to treatment was able to tolerate solids. UGIscopy suggested no evidence of disease in the oesophagus and chest X-ray showed re-expansion of the collapsed left lung and also improvement of his general condition with KPS-80. Due to good clinical and radiological response, he was planned for radical treatment. He received 9 cycles of weekly paclitaxel and carboplatin. Post-chemotherapy UGI-scopy revealed residual disease, a 6 cm lesion in the mid-esophagus and he also had complaints of dysphagia to solids. In view of the above he was treated concurrently with CTRT 50 Gy in 25 fractions with weekly dual agent chemotherapy carboplatin and paclitaxel. The patient tolerated the treatment well and is able to tolerate a solid diet. Currently he is on follow-up.
Conclusions: HDR endobronchial brachytherapy is an effective method to relieve airway obstruction and oesophageal brachytherapy for relief of severe dysphagia promptly for patients and may be considered as a boost for obstructive lesions before chemotherapy and external beam radiation therapy.
Implementing image guided adaptive brachytherapy for carcinoma cervixinstitutional experience Dr. Krishna Sharan, Sarath S Nair, Dr. Amina Beevi Shahabuddin Department of Radiotherapy, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India Purpose: To report the early disease and toxicity outcomes of image guided adaptive brachytherapy for carcinoma cervix treated with definitive radiotherapy.
Material and methods: This retrospective study considered patients with carcinoma cervix treated with curative radiotherapy at our institute. Patients who received image guided brachytherapy using cross-sectional imaging after completion of external-beam radiotherapy were selected. Patients not completing the planned treatment, partially treated with simulator based planning and those receiving palliative RT were excluded. The disease status of the patients at the last follow-up and the toxicities experienced were recorded.
Results: Between April 2017 and December 2018, 34 patients were treated with image guided brachytherapy. Mean age of the patients was 60.7 years (range, 39-78 years). The majority (22; 59.5%) of the patients had stage IIB disease. The average HR-CTV volume at the time of brachytherapy was 19.6 cc (range, 5.7-99 cc). The D 2cc to bladder and rectum were 3.4 (range, 1.2-6.2) Gy and 4.4 (range, 1.4-9.9) Gy, respectively. Mean dose to PIBS was 2.1 Gy (range, 0.5-11.2). Among the 24 patients with a mean followup of 9.7 months (range, 2.1-19.2 months), residual/recurrent disease was noted in two (8.3%). Rectal and bladder toxicities were mild (≤ grade 2) and noted in two patients each. However, vaginal stenosis was frequent (41.7%), with 3 patients (12.5%) experiencing total stenosis.
Conclusions:
Early results of implementing image guided brachytherapy in carcinoma cervix at our institute have been promising, with good locoregional control and low gastrointestinal and genitourinary toxicity, excepting a high incidence of vaginal stenosis.
Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy Dr. U. Usha Rani Department of Radiotherapy, Madras Medical College, Chennai, India Purpose: The mean age of the general population has been prolonged and incidence of cancer in elderly patients has increased. The purpose is to evaluate outcome of brachytherapy as an integrated part of treatment of elderly patients with cervical cancer.
Material and methods: This is a retrospective analysis of 69 patients of 70 years of age diagnosed with cervical cancer with stage 2B-4A (FIGO) from Jan 2012 to Jan 2016 presented at Radiation Oncology OPD, MMC. They were treated by HDR brachytherapy as part of their treatment.
Results: The median age was 75 years (range 70-80 years). 91% of patients presented with squamous cell carcinoma. The mean point A EQD 2 dose was 82 Gy (range: 80-85). The mean bladder and rectal point doses were 78 Gy and 67 Gy respectively. Rectal, small bowel and urinary tract complications were observed in 15 (21.7%), 3 (4.3%) and 9 patients (13.04%) respectively. Rectal complications grade 1, grade 2, grade 3 incidences were 8 (11.5%), 5 (7.2%) and 2 (2.8%) respectively. Urinary complications grade 1 and grade 2 incidences were 5 (7.2%) and 4 (5.7%) respectively. With a median follow-up of 3 years, 10 patients developed distant metastases and 9 others presented local relapses. The 3-year specific overall survival rate was 86.9% and the corresponding disease-free survival rate was 72.5%.
Conclusions: Elderly women with cervical cancer tolerated brachytherapy well and had excellent local disease-free survival and specific survival rates. Age did not influence the effectiveness of brachytherapy in elderly patients and brachytherapy should be considered whenever possible, even in elderly patients presenting with cervix cancer.
